Determinants of cyclosporine nephrotoxicity following cardiac transplantation.
Martin
M
M
Harefield Hospital, Middlesex, England.
Packham
D
D
Kingswood
C
C
Cairns
H
H
Khaghani
A
A
Thompson
D
D
Yacoub
M
M
D000328:Adult; D001379:Azathioprine / Q000627:therapeutic use; D003404:Creatinine / Q000097:blood; D003524:Cyclosporins / Q000009:adverse effects* / Q000097:blood / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D016027:Heart Transplantation / Q000276:immunology* / Q000473:pathology / Q000502:physiology; D006801:Humans; D007668:Kidney / Q000187:drug effects / Q000473:pathology*; D008297:Male; D008775:Methylprednisolone / Q000627:therapeutic use
D003524:Cyclosporins; D003404:Creatinine; D001379:Azathioprine; D008775:Methylprednisolone